Polyneuron Pharmaceuticals AG extends Series A financing
HBM Healthcare’s CHF14m investment brings Polyneuron Pharmaceuticals AG’s Series A round to a total of CHF 36.5m. Upon the financing, Dr Emil...
ADC company Araris Biotech raises CHF15.2m
Besides Pureos Bioventures, London-based 4BIO Capital, btov Partners, Redalpine, VI Partners and Schroder Adveq cofinanced the CHF12.7m addition to...
AI predicts mutations underlying neurological diseases
The approach of the team from Luxemburg, the UK and the US, identifies the impact of mutations that affect gene activity in voltage-gated...
Mabion to licence COVID-19 jab from Vaxine Pty Ltd
Currently, the Australian influenza vaccine and adjuvant specialist and the Polish protein drug maker have just inked a memorandum of understanding,...
Pureos Bioventures closes US$170m fund
Pureos Bioventures’ founding partners Klaus Breiner, Dominik Escher, and Martin Münchbach didn't disclose specific names of investors who committed...
Nobel Prize in Physiology for HCV pioneers
The Nobel Assembly at Karolinska Institute has today decided to award the 2020 Nobel Prize in Physiology or Medicine jointly to Harvey...